Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations

MLA

Jeffrey P. Anderson, et al. “Comparison and Predictors of Treatment Adherence and Remission among Patients with Schizophrenia Treated with Paliperidone Palmitate or Atypical Oral Antipsychotics in Community Behavioral Health Organizations.” BMC Psychiatry, vol. 17, no. 1, Oct. 2017, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12888-017-1507-8.

APA

Jeffrey P. Anderson, Zeynep Icten, Veronica Alas, Carmela Benson, & Kruti Joshi. (2017). Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations. BMC Psychiatry, 17(1), 1–10. https://doi.org/10.1186/s12888-017-1507-8

Chicago

Jeffrey P. Anderson, Zeynep Icten, Veronica Alas, Carmela Benson, and Kruti Joshi. 2017. “Comparison and Predictors of Treatment Adherence and Remission among Patients with Schizophrenia Treated with Paliperidone Palmitate or Atypical Oral Antipsychotics in Community Behavioral Health Organizations.” BMC Psychiatry 17 (1): 1–10. doi:10.1186/s12888-017-1507-8.